Study summary · research use only
Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study in thoroughbred horses characterized ibutamoren (MK-0677), a non-peptide growth hormone secretagogue, and its metabolites after oral administration, using liquid chromatography/high-resolution mass spectrometry for doping control purposes. The abstract reports 22 metabolites of ibutamoren were identified (17 phase I and 5 phase II), including hydroxylated (mono and di) metabolites from oxidation, dissociated side chains (benzyl group and 2-amino-2-methylpropanamide), hydrogenated metabolites, and glucuronic acid conjugated analogs in phase II, with no sulfonic acid conjugated analogs observed. The authors report major metabolites could be detected up to 96 hours after a single dose, and ibutamoren itself could persist for up to 72 hours.
Abstract
It is important to remember that performance-enhancing agents such as non-peptide growth hormone secretagogues present a significant risk of abuse. Ibutamoren (MK-0677) is a potent, long-acting, selective non-peptide growth hormone secretagogue that can be taken orally. This study examines ibutamoren and its metabolites in thoroughbred horses after oral administration. Liquid chromatography/high-resolution mass spectrometry was used to determine the probable structures of the detected metabolites. In this study, 22 metabolites of ibutamoren were identified (17 phase I and 5 phase II). Oxidation of ibutamoren leads to hydroxylated metabolites (mono and di). The study also detected dissociated side chains (benzyl group and 2-amino-2-methylpropanamide) and hydrogenated metabolites. The glucuronic acid conjugated analogs of ibutamoren were detected during phase II of the study, but no sulfonic acid conjugated analogs were observed. The major metabolites can be detected up to 96 hours after a single dose, and ibutamoren can persist for up to 72 hours. These findings will aid in the detection of ibutamoren and the detection of its illegal use in competitive sports.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.